Non-linear relationship between soluble interleukin-2 receptor and prognosis of diffuse large B-cell lymphoma
Annals of Hematology · 2024
DOI: 10.1007/s00277-024-06064-5 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Annals of Hematology, 2024. Verfasst von Hikaru Tsukasaki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Receptors, Interleukin-2. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Despite an emphasis on the prognostic impact of serum soluble interleukin-2 receptor (sIL-2R) at diagnosis in patients with diffuse large B-cell lymphoma (DLBCL), whether the prognostic impact of elevated sIL-2R is linear remains unclear. To verify the presence of a non-linear association between sIL-2R level at diagnosis and overall survival (OS) in patients with newly diagnosed DLBCL, we conducted a multi-center, observational retrospective study. Among 488 analyzable patients, Cox proportional hazards modeling identified serum sIL-2R level at diagnosis as an independent predictor of OS. Multivariate Cox hazard modeling with restricted cubic spline model demonstrated that the relationship between serum sIL-2R level and OS was clearly non-linear (P for effect of sIL-2R = 0.002; P for non-linearity = 0.015). Mortality risk increased gradually as sIL-2R levels increased and plateaued at approximately 5,000 U/mL. Segmented regression analysis revealed that the trend in negative prognostic impact from a gradual increase in serum sIL-2R level changed significantly, with a breakpoint at approximately 2,000 U/mL. Multivariate receiver operating characteristic curves showed a significant improvement in prediction ability when serum sIL-2R level was added to the International Prognostic Index (IPI). Serum sIL-2R level at diagnosis was not only a prognostic factor, but also improved predictive accuracy for OS when incorporated with the IPI. However, the negative correlation between increasing sIL-2R and prognosis was non-linear.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
- Department of Hematology, Osu Hospital, Aichi, Japan.
- Department of Hematology and Oncology, Matsunami General Hospital, 185-1 Kasamatsu-cho, Hashima-gun, Gifu, 501-6062, Japan.
- Department of Internal Medicine, Matsunami General Hospital, Gifu, Japan.
- Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan. leesin.581020@gmail.com.
- Department of Hematology and Oncology, Matsunami General Hospital, 185-1 Kasamatsu-cho, Hashima-gun, Gifu, 501-6062, Japan. leesin.581020@gmail.com.
Zitieren
APA
Tsukasaki, H., Fujita, K., Lee, S., Morishita, T., Oiwa, K., Negoro, E., Hara, T., Tsurumi, H., Ueda, T., & Yamauchi, T. (2024). Non-linear relationship between soluble interleukin-2 receptor and prognosis of diffuse large B-cell lymphoma. Annals of Hematology. https://doi.org/10.1007/s00277-024-06064-5
Vancouver
Tsukasaki H, Fujita K, Lee S, Morishita T, Oiwa K, Negoro E, et al. Non-linear relationship between soluble interleukin-2 receptor and prognosis of diffuse large B-cell lymphoma. Annals of Hematology. 2024. doi:10.1007/s00277-024-06064-5
BibTeX
@article{Tsukasaki2024,
author = {Tsukasaki, Hikaru and Fujita, Kei and Lee, Shin and Morishita, Tetsuji and Oiwa, Kana and Negoro, Eiju and Hara, Takeshi and Tsurumi, Hisashi and Ueda, Takanori and Yamauchi, Takahiro},
title = {Non-linear relationship between soluble interleukin-2 receptor and prognosis of diffuse large B-cell lymphoma},
journal = {Annals of Hematology},
year = {2024},
doi = {10.1007/s00277-024-06064-5}
}
EUVIMED